Follow-up after urinary diversion

被引:0
作者
Christopher Netsch [1 ]
Simon Filmar [1 ]
Sophia Hook [1 ]
Clemens Rosenbaum [1 ]
Andreas J. Gross [1 ]
Benedikt Becker [1 ]
机构
[1] Abteilung für Urologie, Asklepios Klinik Barmbek, Rübenkamp 220, Hamburg
关键词
Complications; Cystectomy; Distant metastases; Recurrence; Urinary bladder neoplasms;
D O I
10.1007/s00120-024-02401-8
中图分类号
学科分类号
摘要
Radical cystectomy is currently the standard of care for muscle-invasive bladder cancer. Different parts of the small and large intestines can be utilized for continent and incontinent urinary diversion. The postoperative follow-up after urinary diversion should consider functional, metabolic and oncological aspects. The functional follow-up of (continent) urinary diversion includes stenosis, emptying disorders or incontinence. The oncological follow-up should focus on the detection of local, urethral and upper tract recurrences as well as distant metastases. As 90% of the tumor recurrences occur during the first 3 years, a close follow-up should be carried out during this period. Metabolic disturbances, such as vitamin B12 and bile acid deficits, acidosis and disorders of calcium metabolism can also occur during long-term follow-up. The metabolic follow-up should consider the metabolic consequences of the parts of the intestines utilized for the urinary diversion. © The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2024.
引用
收藏
页码:1050 / 1059
页数:9
相关论文
共 87 条
  • [1] Zlotta A.R., Ballas L.K., Niemierko A., Et al., Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis, Lancet Oncol, 24, pp. 669-681, (2023)
  • [2] Flegar L., Kraywinkel K., Zacharis A., Et al., Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019, World J Urol, 40, pp. 1715-1721, (2022)
  • [3] Klemm J., Fisch M., Laukhtina E., Et al., Continent diversion is losing its momentum: a nationwide trend analysis from Germany 2005–2021, BJU Int, 133, pp. 154-157, (2024)
  • [4] Hautmann R.E., Abol-Enein H., Lee C.T., Et al., Urinary diversion: how experts divert, Urology, 85, pp. 233-238, (2015)
  • [5] Giannarini G., Kessler T.M., Thoeny H.C., Et al., Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?, Eur Urol, 58, pp. 486-494, (2010)
  • [6] Volkmer B.G., Schnoeller T., Kuefer R., Et al., Upper urinary tract recurrence after radical cystectomy for bladder cancer—who is at risk?, J Urol, 182, pp. 2632-2637, (2009)
  • [7] Witjes J.A., Bruins H.M., Carrion A., Et al., EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer, (2024)
  • [8] S3 Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms, (2020)
  • [9] Strope S.A., Chang S.H., Chen L., Et al., Survival impact of followup care after radical cystectomy for bladder cancer, J Urol, 190, pp. 1698-1703, (2013)
  • [10] Madersbacher S., Schmidt J., Eberle J.M., Et al., Long-term outcome of ileal conduit diversion, J Urol, 169, pp. 985-990, (2003)